Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose Tissue.

Auteurs : Busser H, Najar M, Raicevic G, Pieters K, Velez Pombo R, Philippart P, Meuleman N, Bron D, Lagneaux L
Année : 2015
Journal : Stem Cells Dev.
Volume : 24(18)
Pages : 2142-57

Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control.

Auteurs : Crompot E, Van Damme M, Duvillier H, Pieters K, Vermeesch M, Perez-Morga D, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Année : 2015
Journal : PLoS One
Volume : 10(5)
Pages : e0127209

Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients.

Auteurs : Rombout A, Stamatopoulos B, Lagneaux L, Lust S, Offner F, Naessens E, Vanderstraeten H, Verhasselt B, Philippé J
Année : 2015
Journal : PLoS One
Volume : 10(3)
Pages : e0121526

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Auteurs : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Année : 2015
Journal : Mol. Med.
Volume : 21(1)
Pages : 123-33

Evaluation of a new standardized enzymatic isolation protocol for human umbilical cord-derived stem cells.

Auteurs : Buyl K, Vanhaecke T, Desmae T, Lagneaux L, Rogiers V, Najar M, De Kock J
Année : 2015
Journal : Toxicol In Vitro
Volume : 29(6)
Pages : 1254-62.

In vivo production of mesenchymal stromal cells after injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor in the bone marrow of healthy volunteers.

Auteurs : Philippart P, Meuleman N, Stamatopoulos B, Najar M, Pieters K, De Bruyn C, Bron D, Lagneaux L
Année : 2014
Journal : Tissue Eng Part A
Volume : 20(1-2)
Pages : 160-70

Proliferative and phenotypical characteristics of human adipose tissue-derived stem cells: comparison of Ficoll gradient centrifugation and red blood cell lysis buffer treatment purification methods.

Auteurs : Najar M, Rodrigues RM, Buyl K, Branson S, Vanhaecke T, Lagneaux L, Rogiers V, De Kock J
Année : 2014
Journal : Cytotherapy
Volume : 16(9)
Pages : 1220-1228

Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization.

Auteurs : Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, Meuleman N, Bron D, Lagneaux L
Année : 2014
Journal : Stem Cells Dev.
Volume : 23(19)
Pages : 2390-2400

Human skin-derived precursor cells are poorly immunogenic and modulate the allogeneic immune response.

Auteurs : De Kock J, Meuleman P, Raicevic G, Rodrigues RM, Branson S, Meganathan K, De Boe V, Sachinidis A, Leroux-Roels G, Vanhaecke T, Lagneaux L, Rogiers V, Najar M
Année : 2014
Journal : Stem Cells
Volume : 32(8)
Pages : 2215-28

Characterization of hepatic markers in human Wharton's Jelly-derived mesenchymal stem cells.

Auteurs : Buyl K, De Kock J, Najar M, Lagneaux L, Branson S, Rogiers V, Vanhaecke T
Année : 2014
Journal : Toxicol In Vitro
Volume : 28(1)
Pages : 113-9

Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.

Auteurs : Van Damme M, Crompot E, Meuleman N, Mineur P, Dessars B, El Housni H, Bron D, Lagneaux L, Stamatopoulos B
Année : 2014
Journal : Epigenetics
Volume : 9(10)
Pages : 1374-81

Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Meuleman N, Stamatopoulos B, De Bruyn C, Pieters K, Bron D, Lagneaux L
Année : 2013
Journal : PLoS One
Volume : 8(3)
Pages : e59756

Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Année : 2013
Journal : Int. Immunopharmacol.
Volume : 15(4)
Pages : 693-702

Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin.

Auteurs : Raicevic G, Najar M, Pieters K, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Tissue Eng Part A
Volume : 18(13-14)
Pages : 1410-8

Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.

Auteurs : Najar M, Raicevic G, Jebbawi F, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Immunol. Lett.
Volume : 146(1-2)
Pages : 50-6

Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Kazan HF, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1188-98

AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell -based microenvironment: preclinical evidence for its association with chronic lymphocytic leukemia treatments.

Auteurs : Stamatopoulos B, Meuleman N, De Bruyn C, Pieters K, Mineur P, Le Roy C, Saint-Georges S, Varin-Blank N, Cymbalista F, Bron D, Lagneaux L
Année : 2012
Journal : Haematologica
Volume : 97(4)
Pages : 608-615

HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Année : 2012
Journal : Epigenetics
Volume : 7(12)
Pages : 1403-1412

Erratum to: Immune-Related Antigens, Surface Molecules and Regulatory Factors in Human-Derived Mesenchymal Stromal Cells: The Expression and Impact of Inflammatory Priming.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Année : 2012
Journal : Stem Cell Rev
Volume : 8(4)
Pages : 1286

Mesoderm-Derived Stem Cells: The Link Between the Transcriptome and Their Differentiation Potential.

Auteurs : De Kock J, Najar M, Bolleyn J, Al Battah F, Rodrigues RM, Buyl K, Raicevic G, Govaere O, Branson S, Meganathan K, Gaspar JA, Roskams T, Sachinidis A, Lagneaux L, Vanhaecke T, Rogiers V
Année : 2012
Journal : Stem Cells Dev.
Volume : 21(18)
Pages : 3309-3323